title: The potential benefit of non-purified islets preparations for islet transplantation.
abstract: Since the advent of islet transplantation, there has been a significant emphasis on the importance of islet purity despite an inevitable associated loss of islet mass during the purification process. One of the key elements of the 'Edmonton Protocol' for islet transplantation published in 2000 was an emphasis on the need for sequential transplants of highly purified islets (averaging 24% beta cell purity) and the close correlation between the numbers of islets transplanted and the success of the procedure. However, the emphasis on islet purity may warrant further consideration as auto transplantation of non-purified islets currently provides the most successful insulin independence rates within the field of islet transplantation. While the role of auto and allo immunity could contribute to the differences in the success rates it is clear that within the clinical setting, significant acinar and ductal contamination is well tolerated. However, one could go further and hypothesize that extra-insular tissue including acinar tissue, ductal tissue, peri-pancreatic lymph nodes and vascular tissue actually confer an advantage to islet survival/function and may even contribute to the insulin secreting capacity of the graft post transplant. As such this review will assess the influence of extra-insular pancreatic tissue on the results of islet transplantation based on published evidence and will also explore the possibility that non-islet pancreatic cells are capable of differentiating into a beta cell phenotype in vivo contributing to an ongoing regeneration of endocrine mass during the period following transplantation.
authors.affiliation: Department of Hepatobiliary Surgery, University Hospitals of Leicester, NHS Trust, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK. balu.webb@uhl-tr.nhs.uk
authors.forename: M'Balu A
authors.initials: MA
authors.lastname: Webb
authors.forename: Ashley R
authors.initials: AR
authors.lastname: Dennison
authors.forename: Roger F
authors.initials: RF
authors.lastname: James
mesh_terms: D061354:Acinar Cells / Q000166:cytology; D000818:Animals; D002454:Cell Differentiation; D002469:Cell Separation / Q000379:methods*; D054338:Cell Transdifferentiation; D006224:Cricetinae; D003920:Diabetes Mellitus / Q000601:surgery / Q000628:therapy*; D006085:Graft Survival; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation / Q000379:methods* / Q000473:pathology; D051379:Mice; D010183:Pancreatic Ducts / Q000166:cytology; D051381:Rats
chemical_list: D007328:Insulin